Oncotarget
The cover for issue 11 of Oncotarget features Figure 6, "Effects of AZD8186 in combination with anti-PD1 on syngeneic models," by Owusu-Brackett, et al.
Quizartinib, a selective FLT3 inhibitor, maintains antileukemic activity in preclinical models of RAS-mediated midostaurin-resistant acute myeloid leukemia cells |
https://doi.org/10.18632/oncotarget.27489 Tomoya Aikawa, Noriko Togashi, Koichi Iwanaga, Hiroyuki Okada, Yumi Nishiya, Shinichi Inoue, Mark J. Levis, and Takeshi Isoyama |
943-955 |
Abstract | PDF | Full Text | Supplementary Information | How to cite | Press Release | Order a Reprint |
DOT1L inhibition is lethal for multiple myeloma due to perturbation of the endoplasmic reticulum stress pathway |
https://doi.org/10.18632/oncotarget.27493 Caroline Dafflon, Swann Gaulis, Louise Barys, Karen Kapur, Vanessa Cornacchione, Lina Schukur, Sebastian Bergling, Elisabetta Traggiai, Selina Jansky, Leon Hellmann, Barbara Schacher Engstler, Grainne Kerr, Antoine de Weck, David A. Ruddy, Ulrike Naumann, Frédéric Stauffer, Christoph Gaul, Ying Lin, Eric Billy, Andreas Weiss, Francesco Hofmann, Moriko Ito, and Ralph Tiedt |
956-968 |
Abstract | PDF | Full Text | Supplementary Information | How to cite | Press Release | Order a Reprint |
Targeting PI3Kβ alone and in combination with chemotherapy or immunotherapy in tumors with PTEN loss |
https://doi.org/10.18632/oncotarget.27503 Nicci Owusu-Brackett, Ming Zhao, Argun Akcakanat, Kurt W. Evans, Erkan Yuca, Ecaterina Ileana Dumbrava, Filip Janku, and Funda Meric-Bernstam |
969-981 |
Abstract | PDF | Full Text | Supplementary Information | How to cite | Press Release | Order a Reprint |
Early prediction of resistance to tyrosine kinase inhibitors by plasma monitoring of EGFR mutations in NSCLC: a new algorithm for patient selection and personalized treatment |
https://doi.org/10.18632/oncotarget.27517 Fiamma Buttitta, Lara Felicioni, Alessia Di Lorito, Alessio Cortellini, Luciana Irtelli, Davide Brocco, Pietro Di Marino, Donatella Traisci, Nicola D’Ostilio, Alessandra Di Paolo, Francesco Malorgio, Pasquale Assalone, Sonia Di Felice, Francesca Fabbri, Giovanni Cianci, Michele De Tursi, and Antonio Marchetti |
982-991 |
Abstract | PDF | Full Text | How to cite | Press Release | Order a Reprint |
Acute promyelocytic leukemia (APL): a review of the literature |
https://doi.org/10.18632/oncotarget.27513 Joaquin J. Jimenez, Ravinder S. Chale, Andrea C. Abad, and Andrew V. Schally |
992-1003 |
Abstract | PDF | Full Text | How to cite | Press Release | Order a Reprint |
Correction: A new bioluminescent reporter system to study the biodistribution of systematically injected tumor-derived bioluminescent extracellular vesicles in mice |
https://doi.org/10.18632/oncotarget.27473 Prakash Gangadaran, Xiu Juan Li, Ho Won Lee, Ji Min Oh, Senthilkumar Kalimuthu, Ramya Lakshmi Rajendran, Seung Hyun Son, Se Hwan Baek, Thoudam Debraj Singh, Liya Zhu, Shin Young Jeong, Sang-Woo Lee, Jaetae Lee, and Byeong-Cheol Ahn |
1004-1005 |
Correction | PDF | How to cite |
Correction: Enhanced tumorigenicity by mitochondrial DNA mild mutations |
https://doi.org/10.18632/oncotarget.27522 Alberto Cruz-Bermúdez, Carmen G. Vallejo, Ramiro J. Vicente-Blanco, María Esther Gallardo, Miguel Ángel Fernández-Moreno, Miguel Quintanilla, and Rafael Garesse |
1006-1006 |
Correction | PDF | How to cite |
Copyright © 2021 Impact Journals, LLC
Impact Journals is a registered trademark of Impact Journals, LLC